Implicit Bioscience Limited

Expanded access to investigational products continues to evolve as pharma companies devote more resources to their programs and explore ways to engage patients and utilize data collected outside clini

As a small, privately held biotech, the Australian venture Implicit Bioscience believes its business model has a number of advantages, low risk being chief among them. The firm has so far received